144 related articles for article (PubMed ID: 16759721)
1. A case of fatal stent thrombosis after Carbostent implantation: is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy?
Niccoli G; Siviglia M; De Vita M; Altamura L; Fusco B; Leone AM; Ferrante G; Rebuzzi AG; Crea F
Int J Cardiol; 2007 Jan; 114(2):279-81. PubMed ID: 16759721
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
4. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
Bhatt SH; Hauser TH
Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
[TBL] [Abstract][Full Text] [Related]
5. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery stenting in patients treated by clopidogrel without aspirin.
Rott D; Leibowitz D; Amit G; Zahger D; Weiss AT
Int J Cardiol; 2009 Apr; 133(2):279-81. PubMed ID: 18178268
[TBL] [Abstract][Full Text] [Related]
7. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
Yan BP; Gurvitch R; Ajani AE
Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
9. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
Milicic D; Skoric B; Lovric D
J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
Singh S; Arora R; Khraisat A; Handa K; Bahekar A; Trivedi A; Khosla S
J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):298-303. PubMed ID: 18172224
[TBL] [Abstract][Full Text] [Related]
11. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
Denardo SJ; Davis KE; Tcheng JE
Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
[TBL] [Abstract][Full Text] [Related]
13. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
Silber S; Richartz BM; Brilmayer M;
Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
[TBL] [Abstract][Full Text] [Related]
14. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
15. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
[TBL] [Abstract][Full Text] [Related]
16. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
de Carvalho HC
Rev Port Cardiol; 1999 Jun; 18(6):657-8. PubMed ID: 10422464
[No Abstract] [Full Text] [Related]
18. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
Lemesle G; Delhaye C; Sudre A; Broucqsault D; Rosey G; Bauters C; Lablanche JM
Am Heart J; 2009 Feb; 157(2):375-82. PubMed ID: 19185648
[TBL] [Abstract][Full Text] [Related]
19. Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
Maeng M; Jensen LO; Kaltoft A; Hansen HH; Bøttcher M; Lassen JF; Thayssen P; Krusell LR; Rasmussen K; Pedersen L; Sørensen HT; Johnsen SP; Thuesen L
Am J Cardiol; 2008 Jul; 102(2):165-72. PubMed ID: 18602515
[TBL] [Abstract][Full Text] [Related]
20. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
